Cithera https://cithera-ipsc.com Center for IPS cell therapy Thu, 09 Jun 2022 13:32:34 +0000 fr-FR hourly 1 https://wordpress.org/?v=6.9.4 CiTHERA, lauréat du Grand Défi « Biomédicaments » du gouvernement, dans le cadre de son projet SOFTCELL https://cithera-ipsc.com/cithera-laureat-du-grand-defi-biomedicaments-du-gouvernement-dans-le-cadre-de-son-projet-softcell/ Fri, 03 Jun 2022 09:23:59 +0000 https://cithera-ipsc.com/?p=213805 Communiqué presse – Laureats grand defis biomedicaments – Fevrier 2022

]]> AACR Annual Meeting 2022 – April 8 – 13, 2022 https://cithera-ipsc.com/aacr-annual-meeting-2022-april-8-13-2022/ Mon, 28 Mar 2022 12:25:30 +0000 https://cithera-ipsc.com/?p=213789 AACR Annual Meeting 2022 – April 8 – 13, 2022
Ernest N. Morial Convention Center – New Orleans, Louisiana
https://www.aacr.org/meeting/aacr-annual-meeting-2022/

]]> The 2022 ISSCR Annual Meeting – 15-18 June 2022 https://cithera-ipsc.com/the-2022-isscr-annual-meeting-15-18-june-2022/ Mon, 28 Mar 2022 12:24:52 +0000 https://cithera-ipsc.com/?p=213787
The Global Stem Cell Event – San Francisco, USA –
https://www.isscr.org/meetings-events/annual-meetings/isscr-annual-meeting-2022
]]> INSERM U1310 publishes a review on IPSC derived organoids https://cithera-ipsc.com/inserm-u1310-publishes-a-review-on-ipsc-derived-organoids/ Mon, 28 Mar 2022 12:23:01 +0000 https://cithera-ipsc.com/?p=213785 INSERM U1310 publishes a review on IPSC derived organoids
https://pubmed.ncbi.nlm.nih.gov/34722569/

]]> Novel immunotherapy potential of iPSC https://cithera-ipsc.com/novel-immunotherapy-potential-of-ipsc/ Mon, 28 Mar 2022 12:21:40 +0000 https://cithera-ipsc.com/?p=213783 Novel immunotherapy potential of iPSC: INSERM U1310 reports the major potential of IPSC as
cancer vaccines
read the article here : https://pubmed.ncbi.nlm.nih.gov/34957134/

]]> Potential of iPSC-derived Mesenchymal stem cells for therapy of COVID-19-associated organ failure reported by INSERM 1310 https://cithera-ipsc.com/potential-of-ipsc-derived-mesenchymal-stem-cells-for-therapy-of-covid-19-associated-organ-failure-reported-by-inserm-1310/ Mon, 28 Mar 2022 12:20:17 +0000 https://cithera-ipsc.com/?p=213781 Potential of iPSC-derived Mesenchymal stem cells for therapy of COVID-19-associated organ
failure reported by INSERM 1310
read the article here : https://pubmed.ncbi.nlm.nih.gov/33237619/

]]> CITHERA and INSERM U1310 are part of the Horizon Europe call: HORIZON-HLTH-TOOL-2021-06- 02 https://cithera-ipsc.com/cithera-and-inserm-u1310-are-part-of-the-horizon-europe-call-horizon-hlth-tool-2021-06-02/ Mon, 28 Mar 2022 12:18:03 +0000 https://cithera-ipsc.com/?p=213779 CITHERA and INSERM U1310 are part of the Horizon Europe call: HORIZON-HLTH-TOOL-2021-06-
02: Next generation advanced therapies to treat prevalent and high burden diseases with unmet
needs

]]> New label for INSERM U935 /UA9 https://cithera-ipsc.com/new-label-for-inserm-u935-ua9-2/ Mon, 28 Mar 2022 12:00:37 +0000 https://cithera-ipsc.com/?p=213777 After evaluation by the INSERM scientific committee CSS2
(Cancer), INSERM U935 has been renewed as a monothematic Inserm Unit UMRS 1310 under
the direction of Pr. Ali Turhan. The Unit, in close collaboration with CITHERA is developing
cancer and leukemia models for applications to therapy.

]]> CiTHERA, lauréat du Grand Défi « Biomédicaments » du gouvernement https://cithera-ipsc.com/cithera-laureat-du-grand-defi-biomedicaments-du-gouvernement/ Mon, 28 Mar 2022 11:48:35 +0000 https://cithera-ipsc.com/?p=213775 CiTHERA, lauréat du Grand Défi « Biomédicaments » du gouvernement, dans le cadre de son projet SOFTCELL.

Découvrez l’article ici : https://www.univ-evry.fr/toute-lactualite/actualites-recherche/luniversite-devry-et-genopole-engages-dans-trois-projets-parmi-les-huit-laureats-du-grand-defi-biomedicaments.html

]]> New label for INSERM U935 /UA9 https://cithera-ipsc.com/new-label-for-inserm-u935-ua9/ Thu, 24 Feb 2022 18:26:28 +0000 https://cithera-ipsc.com/?p=213765
New label for INSERM U935 /UA9: After evaluation by the INSERM scientific committee CSS2
(Cancer), INSERM U935 has been renewed as a monothematic Inserm Unit UMRS 1310 under
the direction of Pr. Ali Turhan. The Unit, in close collaboration with CITHERA is developing
cancer and leukemia models for applications to therapy.
]]>